Literature DB >> 14508710

NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6).

Shirley Rainier1, Jing-Hua Chai, Debra Tokarz, Robert D Nicholls, John K Fink.   

Abstract

The hereditary spastic paraplegias (HSPs) are genetically heterogeneous disorders characterized by progressive lower-extremity weakness and spasticity. The molecular pathogenesis is poorly understood. We report discovery of a dominant negative mutation in the NIPA1 gene in a kindred with autosomal dominant HSP (ADHSP), linked to chromosome 15q11-q13 (SPG6 locus); and precisely the same mutation in an unrelated kindred with ADHSP that was too small for meaningful linkage analysis. NIPA1 is highly expressed in neuronal tissues and encodes a putative membrane transporter or receptor. Identification of the NIPA1 function and ligand will aid an understanding of axonal neurodegeneration in HSP and may have important therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508710      PMCID: PMC1180617          DOI: 10.1086/378817

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

Review 1.  Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.

Authors:  R D Nicholls; J L Knepper
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

2.  GCP5 and GCP6: two new members of the human gamma-tubulin complex.

Authors:  S M Murphy; A M Preble; U K Patel; K L O'Connell; D P Dias; M Moritz; D Agard; J T Stults; T Stearns
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

3.  Hereditary spastic paraplegia: the pace quickens.

Authors:  John K Fink
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

4.  A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P.

Authors:  A Schenck; B Bardoni; A Moro; C Bagni; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

6.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia.

Authors:  X Zhao; D Alvarado; S Rainier; R Lemons; P Hedera; C H Weber; T Tukel; M Apak; T Heiman-Patterson; L Ming; M Bui; J K Fink
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

7.  p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase.

Authors:  K Kobayashi; S Kuroda; M Fukata; T Nakamura; T Nagase; N Nomura; Y Matsuura; N Yoshida-Kubomura; A Iwamatsu; K Kaibuchi
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

8.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.

Authors:  Jens Jacob Hansen; Alexandra Dürr; Isabelle Cournu-Rebeix; Costa Georgopoulos; Debbie Ang; Marit Nyholm Nielsen; Claire-Sophie Davoine; Alexis Brice; Bertrand Fontaine; Niels Gregersen; Peter Bross
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

9.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10).

Authors:  Evan Reid; Mark Kloos; Allison Ashley-Koch; Lori Hughes; Simon Bevan; Ingrid K Svenson; Felicia Lennon Graham; Perry C Gaskell; Andrew Dearlove; Margaret A Pericak-Vance; David C Rubinsztein; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2002-09-24       Impact factor: 11.025

Review 10.  Hereditary spastic paraplegia: genetic heterogeneity and genotype-phenotype correlation.

Authors:  J K Fink; P Hedera
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

View more
  65 in total

1.  TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation.

Authors:  Maria Martinez-Lage; Laura Molina-Porcel; Dana Falcone; Leo McCluskey; Virginia M-Y Lee; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-08       Impact factor: 17.088

2.  Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Zohreh Talebizadeh; Daniel J Driscoll; Merlin G Butler
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

3.  Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules.

Authors:  Xinnan Wang; W Robert Shaw; Hilda T H Tsang; Evan Reid; Cahir J O'Kane
Journal:  Nat Neurosci       Date:  2007-01-14       Impact factor: 24.884

4.  NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe.

Authors:  Stephan Klebe; Arnaud Lacour; Alexandra Durr; Tanya Stojkovic; Christel Depienne; Sylvie Forlani; Sandrine Poea-Guyon; Isabelle Vuillaume; Bernard Sablonniere; Patrick Vermersch; Alexis Brice; Giovanni Stevanin
Journal:  Neurogenetics       Date:  2007-01-05       Impact factor: 2.660

5.  A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia.

Authors:  Johanna A Reed; Phillip A Wilkinson; Heema Patel; Michael A Simpson; Arnaud Chatonnet; Dimitri Robay; Michael A Patton; Andrew H Crosby; Thomas T Warner
Journal:  Neurogenetics       Date:  2005-02-12       Impact factor: 2.660

Review 6.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

7.  Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.

Authors:  P Hande Ozdinler; Susanna Benn; Ted H Yamamoto; Mine Güzel; Robert H Brown; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

8.  Novel SPG11 mutations in Asian kindreds and disruption of spatacsin function in the zebrafish.

Authors:  Laura Southgate; Dimitra Dafou; Jacqueline Hoyle; Nan Li; Esther Kinning; Peter Critchley; Andrea H Németh; Kevin Talbot; Parayil S Bindu; Sanjib Sinha; Arun B Taly; Seetharam Raghavendra; Ferenc Müller; Eamonn R Maher; Richard C Trembath
Journal:  Neurogenetics       Date:  2010-10       Impact factor: 2.660

9.  Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking.

Authors:  Jiali Zhao; Peter Hedera
Journal:  Mol Cell Neurosci       Date:  2012-10-16       Impact factor: 4.314

10.  The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling.

Authors:  Hilda T H Tsang; Thomas L Edwards; Xinnan Wang; James W Connell; Rachel J Davies; Hannah J Durrington; Cahir J O'Kane; J Paul Luzio; Evan Reid
Journal:  Hum Mol Genet       Date:  2009-07-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.